Williams v. Dunn et al

On March 17, 2025, the U.S. District Court for the Middle District of Alabama issued a landmark ruling in Williams v. Dunn et al., a civil rights action filed by death-row inmate Marcus Williams. Williams challenged Alabama's three-drug lethal injection protocol, asserting that the initial drug, midazolam, cannot maintain an adequate anesthetic plane, causing inmates to experience excruciating pain from the subsequent paralytic and potassium chloride injections. This, he argued, violates the Eighth Amendment's prohibition against cruel and unusual punishment. After reviewing extensive expert testimony and evidence from prior executions, the court found that Williams demonstrated a substantial risk of severe suffering and identified a readily available, less-painful alternative—a single high-dose barbiturate. The court consequently held the existing protocol unconstitutional and enjoined its use unless the state adopted the alternative or implemented stringent, independent consciousness assessments.

The district court granted a permanent injunction barring the state from executing Williams under the challenged three-drug protocol. The injunction would be lifted only if Alabama adopted a single-drug barbiturate protocol or incorporated rigorous, medically verified consciousness checks to ensure the inmate does not experience pain.

Whether Alabama's three-drug lethal injection protocol, relying on midazolam, creates a demonstrated risk of severe pain sufficient to violate the Eighth Amendment's ban on cruel and unusual punishment.

The decision intensified national scrutiny of lethal injection secrecy and protocols, prompted legislative debates in multiple states over execution transparency and the procurement of alternative drugs, and reinforced a judicial trend requiring states to adopt less painful execution methods when available.